Jordan E Axelrad (Jordan Axelrad)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 56

Top Venues

The American journal of gastroenterology

Inflammatory bowel diseases

Alimentary pharmacology & therapeutics

Therapeutic advances in gastroenterology

NYU Langone Health

Tufts University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU Langone Health Jul 01 2018

United States

Assistant Professor :: Medicine, Gastroenterology

Columbia University Medical Center Jul 01 2015

United States

Gastroenterology Fellow :: Medicine, Division of Digestive and Liver Diseases

Mount Sinai Hospital Jul 01 2012 - Jun 30 2015

United States

Internal Medicine Resident :: Medicine

Education History

Tufts University Sep 07 2004 - May 20 2008

United States

BSC :: Biology-Psychology, Biomedical Engineering

Publications

Ravi S Shah, Jessica H Hu, Salam P Bachour, Abel Joseph, Hareem Syed, Qijun Yang, Adel Hajj Ali, Terry Li, Sussell Contreras, Shravya Pothula, Vall Vinaithirthan, Miguel Regueiro, Jordan E Axelrad, Edward L Barnes, Benjamin L Cohen, Benjamin H Click
Histologic Activity From Neoterminal Ileal Biopsies in Patients With Crohn's Disease in Endoscopic Remission is Associated With Postoperative Recurrence. The American journal of gastroenterology (2024)
Ravi S Shah, Jessica H Hu, Salam P Bachour, Abel Joseph, Hareem Syed, Qijun Yang, Adel Hajj Ali, Terry Li, Sussell Contreras, Shravya Pothula, Vall Vinaithirthan, Miguel Regueiro, Jordan E Axelrad, Edward L Barnes, Benjamin L Cohen, Benjamin H Click
Histologic Activity from Neoterminal Ileal Biopsies in Patients with Crohn's Disease in Endoscopic Remission is Associated with Postoperative Recurrence. The American journal of gastroenterology (2024)
Karl Mårild, Jonas Söderling, Jordan E Axelrad, Jonas Halfvarson, Anders Forss, null null, Karl Michaëlsson, Ola Olén, Jonas F Ludvigsson
A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk. Alimentary pharmacology & therapeutics (2024)
Terry Li, Ravi Shah, Benjamin Click, Benjamin L Cohen, Edward Barnes, Abel Joseph, Salam Bachour, Jessica Hu, Susell Contreras, Elizabeth Li, Jordan E Axelrad
American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn's Disease Post-ileocolic Resection. Crohn's & colitis 360 6 (1) (2024)
Jessica R Allegretti, Jordan E Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer
Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection. The American journal of gastroenterology 119 (7) (2024)
Jessica R Allegretti, Jordan E Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer
Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection. The American journal of gastroenterology (2024)
Jessica R Allegretti, Jordan E Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer
Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection. The American journal of gastroenterology (2024)
Terry Li, Ravi Shah, Benjamin Click, Benjamin L Cohen, Edward Barnes, Abel Joseph, Salam Bachour, Jessica Hu, Susell Contreras, Elizabeth Li, Jordan E Axelrad
American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn's Disease Post-ileocolic Resection. Crohn's & colitis 360 6 (1) (2024)
Jessica R Allegretti, Jordan E Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer
Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C. difficile Infection. The American journal of gastroenterology (2024)
Jessica R Allegretti, Jordan E Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer
Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection. The American journal of gastroenterology 119 (7) (2024)
Jessica R Allegretti, Jordan E Axelrad, Rahul S Dalal, Colleen R Kelly, Ari Grinspan, Monika Fischer
Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection. The American journal of gastroenterology 119 (7) (2024)
Katherine L Stone, Emma Kulekofsky, David Hudesman, Samuel Kozloff, Feza Remzi, Jordan E Axelrad, Seymour Katz, Simon J Hong, Ariela Holmer, Mara A McAdams-DeMarco, Dorry L Segev, John Dodson, Aasma Shaukat, Adam S Faye
Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease. Therapeutic advances in gastroenterology 16 (2023)
Sigrid Young, Briton Lee, Scott Smukalla, Jordan E Axelrad, Shannon Chang
Anorectal Manometry in Patients With Fecal Incontinence After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Cohort Study. Crohn's & colitis 360 5 (4) (2023)
Bingjie Zhang, Rabi Upadhyay, Yuhan Hao, Marie I Samanovic, Ramin Sedaghat Herati, John D Blair, Jordan E Axelrad, Mark J Mulligan, Dan R Littman, Rahul Satija
Multimodal single-cell datasets characterize antigen-specific CD8 + T cells across SARS-CoV-2 vaccination and infection. Nature immunology (2023)
Jordan E Axelrad, Ze Chen, Joseph Devlin, Kelly V Ruggles, Ken Cadwell
Pathogen-Specific Alterations in the Gut Microbiota Predict Outcomes in Flare of Inflammatory Bowel Disease Complicated by Gastrointestinal Infection. Clinical and translational gastroenterology 14 (2) (2023)
Bingjie Zhang, Rabi Upadhyay, Yuhan Hao, Marie I Samanovic, Ramin Sedaghat Herati, John D Blair, Jordan E Axelrad, Mark J Mulligan, Dan R Littman, Rahul Satija
Multimodal characterization of antigen-specific CD8 + T cells across SARS-CoV-2 vaccination and infection. bioRxiv : the preprint server for biology (2023)
Shannon Chang, Simon Hong, David Hudesman, Feza Remzi, Katherine Sun, Wenqing Cao, H Tarik Kani, Jordan E Axelrad, Suparna A Sarkar
Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis. Inflammatory bowel diseases (2023)
Shannon Chang, Simon Hong, David Hudesman, Feza Remzi, Katherine Sun, Wenqing Cao, H Tarik Kani, Jordan E Axelrad, Suparna A Sarkar
Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis. Inflammatory bowel diseases (2023)
Jordan E Axelrad, Ola Olén, Jonas Söderling, Bjorn Roelstraete, Hamed Khalili, Mingyang Song, Adam S Faye, Michael Eberhardson, Jonas Halfvarson, Jonas F Ludvigsson
Inflammatory Bowel Disease and Risk of Colorectal Polyps: A nationwide population-based cohort study from Sweden. Journal of Crohn's & colitis (2023)
Jordan E Axelrad, Ze Chen, Joseph Devlin, Kelly V Ruggles, Ken Cadwell
Pathogen-Specific Alterations in the Gut Microbiota Predict Outcomes in Flare of Inflammatory Bowel Disease Complicated by Gastrointestinal Infection. Clinical and translational gastroenterology 14 (2) (2023)
Bingjie Zhang, Rabi Upadhyay, Yuhan Hao, Marie I Samanovic, Ramin Sedaghat Herati, John D Blair, Jordan E Axelrad, Mark J Mulligan, Dan R Littman, Rahul Satija
Multimodal characterization of antigen-specific CD8 + T cells across SARS-CoV-2 vaccination and infection. bioRxiv : the preprint server for biology (2023)
Bingjie Zhang, Rabi Upadhyay, Yuhan Hao, Marie I Samanovic, Ramin Sedaghat Herati, John D Blair, Jordan E Axelrad, Mark J Mulligan, Dan R Littman, Rahul Satija
Multimodal characterization of antigen-specific CD8 + T cells across SARS-CoV-2 vaccination and infection. bioRxiv : the preprint server for biology (2023)
Abhishek Dimopoulos-Verma, Soonwook Hong, Jordan E Axelrad
Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years. Inflammatory bowel diseases (2023)
Lauren A George, Harris T Feldman, Madeline Alizadeh, Ameer Abutaleb, Samantha Zullow, Ashley Hine, Kristen Stashek, Suparna Sarkar, Katherine Sun, David Hudesman, Jordan E Axelrad, Raymond K Cross
Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission. Crohn's & colitis 360 5 (4) (2023)
Adam S Faye, Jordan E Axelrad, Jiangwei Sun, Jonas Halfvarson, Jonas Söderling, Ola Olén, Jonas F Ludvigsson
Atherosclerosis as a Risk Factor for IBD: A Population-Based Case-Control Study. The American journal of gastroenterology (2023)
Katherine L Stone, Emma Kulekofsky, David Hudesman, Samuel Kozloff, Feza Remzi, Jordan E Axelrad, Seymour Katz, Simon J Hong, Ariela Holmer, Mara A McAdams-DeMarco, Dorry L Segev, John Dodson, Aasma Shaukat, Adam S Faye
Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease. Therapeutic advances in gastroenterology 16 (2023)
Jordan E Axelrad, Ze Chen, Joseph Devlin, Kelly V Ruggles, Ken Cadwell
Pathogen-Specific Alterations in the Gut Microbiota Predict Outcomes in Flare of Inflammatory Bowel Disease Complicated by Gastrointestinal Infection. Clinical and translational gastroenterology 14 (2) (2023)
Jordan E Axelrad, Ze Chen, Joseph Devlin, Kelly V Ruggles, Ken Cadwell
PATHOGEN-SPECIFIC ALTERATIONS IN THE GUT MICROBIOTA PREDICT OUTCOMES IN FLARE OF INFLAMMATORY BOWEL DISEASE COMPLICATED BY GASTROINTESTINAL INFECTION. Clinical and translational gastroenterology (2022)
Gassan Kassim, Clara Yzet, Nilendra Nair, Anketse Debebe, Alexa Rendon, Jean-Frédéric Colombel, Cindy Traboulsi, David T Rubin, Annalisa Maroli, Elisabetta Coppola, Michele M Carvello, Nadat Ben David, Francesca De Lucia, Matteo Sacchi, Silvio Danese, Antonino Spinelli, Meike M C Hirdes, Joren Ten Hove, Bas Oldenburg, Aurada Cholapranee, Maxine Riter, Dana J Lukin, Ellen Scherl, Esen Eren, Keith S Sultan, Jordan E Axelrad, David B Sachar
Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study. Inflammatory bowel diseases (2022)
Kyung Ku Jang, Maria E Kaczmarek, Simone Dallari, Ying-Han Chen, Takuya Tada, Jordan E Axelrad, Nathaniel R Landau, Kenneth A Stapleford, Ken H Cadwell
Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection. PLoS biology 20 (3) (2022)
Jordan E Axelrad, Ze Chen, Joseph Devlin, Kelly V Ruggles, Ken Cadwell
PATHOGEN-SPECIFIC ALTERATIONS IN THE GUT MICROBIOTA PREDICT OUTCOMES IN FLARE OF INFLAMMATORY BOWEL DISEASE COMPLICATED BY GASTROINTESTINAL INFECTION. Clinical and translational gastroenterology (2022)
Salam P Bachour, Ravi S Shah, Florian Rieder, Taha Qazi, Jean Paul Achkar, Jessica Philpott, Bret Lashner, Stefan D Holubar, Amy L Lightner, Edward L Barnes, Jordan E Axelrad, Miguel Regueiro, Benjamin Click, Benjamin L Cohen
Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrence. Journal of Crohn's & colitis 16 (11) (2022)
Simon J Hong, Sumona Bhattacharya, Aiya Aboubakr, Devika Nadkarni, Diana Lech, Ryan C Ungaro, Manasi Agrawal, Robert P Hirten, Ruby Greywoode, Anjali Mone, Shannon Chang, David P Hudesman, Thomas Ullman, Keith Sultan, Dana J Lukin, Jean-Frederic Colombel, Jordan E Axelrad
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study. Therapeutic advances in gastroenterology 15 (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Terry Li, Salam P Bachour, Takahiro I Nakamura, Ravi Shah, Michael C Sachs, Shannon Chang, David P Hudesman, Stefan D Holubar, Amy L Lightner, Edward L Barnes, Benjamin L Cohen, Florian Rieder, Eren Esen, Feza Remzi, Miguel Regueiro, Benjamin Click
Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection. Inflammatory bowel diseases (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Hannah Gordon, Livia Biancone, Gionata Fiorino, Konstantinos H Katsanos, Uri Kopylov, Eman Al Sulais, Jordan E Axelrad, Karthiha Balendran, Burisch J, Lissy de Ridder, Lauranne Derikx, Pierre Ellul, Thomas Greuter, Marietta Iacucci, Caroline Di Jiang, Christina Kapizioni, Konstantinos Karmiris, Julien Kirchgesner, David Laharie, Triana Lobatón Ortega, Tamás Molnár, Nurulamin M Noor, Rohit Rao, Simone Saibeni, Michael Scharl, Stephan R Vavricka, Timothy Raine
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies. Journal of Crohn's & colitis (2022)
Adam S Faye, Jordan E Axelrad
Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes. Alimentary pharmacology & therapeutics 55 (11) (2022)
Salam P Bachour, Ravi S Shah, Ruishen Lyu, Florian Rieders, Taha Qazi, Bret Lashner, Jean Paul Achkar, Jessica Philpott, Edward L Barnes, Jordan E Axelrad, Stefan D Holubar, Amy L Lightner, Miguel Regueiro, Benjamin L Cohen, Benjamin H Click
Mild neoterminal ileal post-operative recurrence of Crohn's disease conveys higher risk for severe endoscopic disease progression than isolated anastomotic lesions. Alimentary pharmacology & therapeutics 55 (9) (2022)
Abhishek Dimopoulos-Verma, Ashley M Hine, Andrew Joelson, Rena Mei, Robert A Pitts, Benjamin Lebwohl, Jordan E Axelrad
The influence of hospitalization and HIV severity on gastrointestinal PCR panel evaluation of HIV-related acute diarrhea in New York City: a retrospective, cross-sectional study. Therapeutic advances in gastroenterology 15 (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Lucie Bernard-Raichon, Mericien Venzon, Jonathan Klein, Jordan E Axelrad, Chenzhen Zhang, Alexis P Sullivan, Grant A Hussey, Arnau Casanovas-Massana, Maria G Noval, Ana M Valero-Jimenez, Juan Gago, Gregory Putzel, Alejandro Pironti, Evan Wilder, null null, Lorna E Thorpe, Dan R Littman, Meike Dittmann, Kenneth A Stapleford, Bo Shopsin, Victor J Torres, Albert I Ko, Akiko Iwasak, Ken Cadwell, Jonas Schluter
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nature communications 13 (1) (2022)
Yu Matsuzawa-Ishimoto, Xiaomin Yao, Akiko Koide, Beatrix M Ueberheide, Jordan E Axelrad, Bernardo Sgarbi Reis, Roham Parsa, Jessica A Neil, Joseph C Devlin, Eugene Rudensky, M Zahidunnabi Dewan, Michael Cammer, Richard S Blumberg, Yi Ding, Kelly V Ruggles, Daniel Mucida, Shohei Koide, Ken H Cadwell
The γδ IEL effector API5 masks genetic susceptibility to Paneth cell death. Nature 610 (7932) (2022)
Jordan E Axelrad, Adam Faye, James C Slaughter, Noam Harpaz, Steven H Itzkowitz, Shailja C Shah
Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia. Inflammatory bowel diseases (2021)
Jordan E Axelrad, Ken H Cadwell, Jean-Frederic Colombel, Shailja C Shah
The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review. Therapeutic advances in gastroenterology 14 (2021)
Mericien Venzon, Lucie Bernard-Raichon, Jonathan Klein, Jordan E Axelrad, Grant Hussey, Alexis Sullivan, Arnau Casanovas-Massana, Maria Noval, Ana Valero-Jimenez, Juan Gago, Evan Wilder, Yale Impact Research Team, Akiko Iwasak, Lorna Thorpe, Dan Littman, Meike Dittmann, Kenneth Stapleford, Bo Shopsin, Victor J Torres, Albert I Ko, Ken Cadwell, Jonas Schluter
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. Research square (2021)
Jordan E Axelrad
Editorial: immune-mediated diseases-are we closer to disease-defining molecular signatures? Alimentary pharmacology & therapeutics 53 (4) (2021)
Abhishek Verma, Sanskriti Varma, Daniel E Freedberg, Jordan E Axelrad
A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease. Digestive diseases and sciences (2021)
H Tarik Kani, Daryl Ramai, Ellen Caniglia, David Hudesman, Jordan E Axelrad, Joseph Nicholson, Simon Hong, Shannon Chang
Systematic review with meta-analysis: a history of smoking is not associated with a higher risk of pouchitis. Alimentary pharmacology & therapeutics 52 (7) (2020)
Jordan E Axelrad, Ola Olén, Michael C Sachs, Rune Erichsen, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Henrik Toft Sørensen, Jonas F Ludvigsson
Reply: Survival in Crohn's disease-associated small bowel adenocarcinoma. Gut 70 (5) (2020)
Jordan E Axelrad, Ken H Cadwell, Jean Frederic Colombel, Shailja C Shah
Systematic review: gastrointestinal infection and incident inflammatory bowel disease. Alimentary pharmacology & therapeutics 51 (12) (2020)
Jessica Kimmel, Jordan E Axelrad
The Complex Interplay Between Inflammatory Bowel Disease and Malignancy. Current gastroenterology reports 22 (3) (2020)
Jordan E Axelrad, Michael C Sachs, Jonas F Ludvigsson, Ola Olén, null null
A Novel Method for Quantifying Intestinal Inflammatory Burden in Inflammatory Bowel Disease Using Register Data. Clinical epidemiology 12 (2020)
Jordan E Axelrad, Ola Olén, Michael C Sachs, Rune Erichsen, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Henrik Toft Sørensen, Jonas F Ludvigsson
Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden. Gut 70 (2) (2020)

Jordan E Axelrad.css-eqlu8i{font-size:small;padding-left:4px;} (Jordan Axelrad)

Publication Activity (10 Years)

Top Topics

Top Venues

Jordan E Axelrad (Jordan Axelrad)